rs121918440
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000443.4(ABCB4):c.2869C>T(p.Arg957Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000443.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCB4 | NM_000443.4 | c.2869C>T | p.Arg957Ter | stop_gained | 23/28 | ENST00000649586.2 | NP_000434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCB4 | ENST00000649586.2 | c.2869C>T | p.Arg957Ter | stop_gained | 23/28 | NM_000443.4 | ENSP00000496956 | P1 | ||
ABCB4 | ENST00000265723.8 | c.2869C>T | p.Arg957Ter | stop_gained | 23/28 | 1 | ENSP00000265723 | |||
ABCB4 | ENST00000359206.8 | c.2869C>T | p.Arg957Ter | stop_gained | 23/28 | 1 | ENSP00000352135 | P1 | ||
ABCB4 | ENST00000453593.5 | c.2783+1669C>T | intron_variant | 5 | ENSP00000392983 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461566Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727076
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74322
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 03, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 25, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 13687). This premature translational stop signal has been observed in individual(s) with familial intrahepatic cholestasis (PMID: 9419367). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg957*) in the ABCB4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCB4 are known to be pathogenic (PMID: 17726488, 25755532). - |
Cholestasis, intrahepatic, of pregnancy, 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 18, 2017 | - - |
Low phospholipid associated cholelithiasis Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 13, 2018 | The ABCB4 c.2869C>T (p.Arg957Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Arg957Ter variant has been reported in two studies and is found in two probands with progressive familial intrahepatic cholestasis, including one in a homozygous state and one in a compound heterozygous state (de Vree et al. 1998; Stalke et al. 2017). Canalicular staining for ABCB4 protein was negative in liver tissue of the homozygous proband, and Northern blot and Western blot analysis showed low level or absence of RNA and protein (de Vree et al. 1998). The homozygous proband was from a consanguineous family and no other probands with liver disease were reported in this family, except for the mother who had experienced episodes of cholestasis during pregnancy (de Vree et al. 1998). Control data are unavailable for this variant and it is not found in the 1000 Genomes Project, the Exome Sequencing Project, the Exome Aggregation Consortium, or the Genome Aggregation Database. Based on the evidence and potential impact of stop-gained variants, this variant is classified as likely pathogenic for ABCB4-related intrahepatic cholestasis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Progressive familial intrahepatic cholestasis type 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 18, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at